Amita Joshi

4.0k total citations
88 papers, 3.0k citations indexed

About

Amita Joshi is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Immunology. According to data from OpenAlex, Amita Joshi has authored 88 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Radiology, Nuclear Medicine and Imaging, 21 papers in Oncology and 19 papers in Immunology. Recurrent topics in Amita Joshi's work include Monoclonal and Polyclonal Antibodies Research (21 papers), HER2/EGFR in Cancer Research (9 papers) and Cervical Cancer and HPV Research (6 papers). Amita Joshi is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (21 papers), HER2/EGFR in Cancer Research (9 papers) and Cervical Cancer and HPV Research (6 papers). Amita Joshi collaborates with scholars based in United States, India and Switzerland. Amita Joshi's co-authors include Sandhya Girish, Manish Gupta, Henry J. Pieniaszek, René Bruno, Lisa A. Damico‐Beyer, Dan Lu, Russell L. Dedrick, David E. Allison, Peter Kuebler and Howard A. Burris and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Amita Joshi

83 papers receiving 2.8k citations

Peers

Amita Joshi
Caroline Chapman United Kingdom
Gabriel J. Robbie United States
James N. Lowder United States
Joseph P. Balthasar United States
Roshini S. Abraham United States
Federico Vázquez Spain
Roberto Ceriani United States
Irit Avivi Israel
W. James Cook United States
Guglielmo Nasti Italy
Caroline Chapman United Kingdom
Amita Joshi
Citations per year, relative to Amita Joshi Amita Joshi (= 1×) peers Caroline Chapman

Countries citing papers authored by Amita Joshi

Since Specialization
Citations

This map shows the geographic impact of Amita Joshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amita Joshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amita Joshi more than expected).

Fields of papers citing papers by Amita Joshi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amita Joshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amita Joshi. The network helps show where Amita Joshi may publish in the future.

Co-authorship network of co-authors of Amita Joshi

This figure shows the co-authorship network connecting the top 25 collaborators of Amita Joshi. A scholar is included among the top collaborators of Amita Joshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amita Joshi. Amita Joshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhu, Rui, Rik C. Schoemaker, Xianbin Tian, et al.. (2024). Model‐based comparisons of post‐treatment free IgE and FEV1 between omalizumab asthma dosing tables in the United States and European Union. British Journal of Clinical Pharmacology. 90(12). 3190–3200. 1 indexed citations
3.
Joshi, Amita, Saroja Ramanujan, & Jin Y. Jin. (2023). The convergence of pharmacometrics and quantitative systems pharmacology in pharmaceutical research and development. European Journal of Pharmaceutical Sciences. 182. 106380–106380. 8 indexed citations
4.
Arrieta, Antonio, Lillian Sung, John S. Bradley, et al.. (2019). A non-randomized trial to assess the safety, tolerability, and pharmacokinetics of posaconazole oral suspension in immunocompromised children with neutropenia. PLoS ONE. 14(3). e0212837–e0212837. 34 indexed citations
5.
Claret, Laurent, Jin Y. Jin, Charles Ferté, et al.. (2018). A Model of Overall Survival Predicts Treatment Outcomes with Atezolizumab versus Chemotherapy in Non–Small Cell Lung Cancer Based on Early Tumor Kinetics. Clinical Cancer Research. 24(14). 3292–3298. 53 indexed citations
6.
Joshi, Amita, et al.. (2018). Pure leydig cell tumour – a rare virilizing tumour in a young female. International Journal of Medical Research and Review. 6(1). 60–64. 1 indexed citations
7.
Kjær, Susanne K., Mari Nygård, Joakim Dillner, et al.. (2017). A 12-Year Follow-up on the Long-Term Effectiveness of the Quadrivalent Human Papillomavirus Vaccine in 4 Nordic Countries. Clinical Infectious Diseases. 66(3). 339–345. 91 indexed citations
8.
Zhang, Yi, Xiaohui Wei, Gaurav Bajaj, et al.. (2015). Challenges and considerations for development of therapeutic proteins in pediatric patients. The Journal of Clinical Pharmacology. 55(S3). S103–15. 25 indexed citations
9.
10.
Almond, Lisa M., Amin Rostami‐Hodjegan, I. Gardner, et al.. (2013). A Physiologically Based Pharmacokinetic Modeling Approach to Predict Disease–Drug Interactions: Suppression of CYP3A by IL-6. Clinical Pharmacology & Therapeutics. 94(2). 260–268. 86 indexed citations
11.
Girish, Sandhya, Manish Gupta, Bei Wang, et al.. (2012). Clinical pharmacology of trastuzumab emtansine (T-DM1): an antibody–drug conjugate in development for the treatment of HER2-positive cancer. Cancer Chemotherapy and Pharmacology. 69(5). 1229–1240. 198 indexed citations
12.
Bender, Brendan C., Amita Joshi, Yu‐Waye Chu, et al.. (2012). A population pharmacokinetic/pharmacodynamic model of thrombocytopenia characterizing the effect of trastuzumab emtansine (T-DM1) on platelet counts in patients with HER2-positive metastatic breast cancer. Cancer Chemotherapy and Pharmacology. 70(4). 591–601. 66 indexed citations
13.
Joshi, Amita, Leslie D. Cope, Edward P. Bowman, et al.. (2012). Immunization withStaphylococcus aureusiron regulated surface determinant B (IsdB) confers protection via Th17/IL17 pathway in a murine sepsis model. Human Vaccines & Immunotherapeutics. 8(3). 336–346. 96 indexed citations
14.
Lu, Dan, Howard A. Burris, Bei Wang, et al.. (2012). Drug Interaction Potential of Trastuzumab Emtansine (T-DM1) Combined with Pertuzumab in Patients With HER2-Positive Metastatic Breast Cancer. Current Drug Metabolism. 13(7). 911–922. 30 indexed citations
15.
Joshi, Amita, Jie Tang, John L. Wagner, et al.. (2008). Adenovirus DNA polymerase is recognized by human CD8+ T cells. Journal of General Virology. 90(1). 84–94. 14 indexed citations
16.
Joshi, Amita, Robert J. Bauer, Peter Kuebler, et al.. (2006). An Overview of the Pharmacokinetics and Pharmacodynamics of Efalizumab: A Monoclonal Antibody Approved for Use in Psoriasis. The Journal of Clinical Pharmacology. 46(1). 10–20. 52 indexed citations
17.
Sun, Yu‐Nien, Jianfeng Lü, Amita Joshi, et al.. (2005). Population Pharmacokinetics of Efalizumab (Humanized Monoclonal Anti‐CD11a Antibody) Following Long‐Term Subcutaneous Weekly Dosing in Psoriasis Subjects. The Journal of Clinical Pharmacology. 45(4). 468–476. 41 indexed citations
18.
Barrett, Jeffrey S., Amita Joshi, Meng Chai, et al.. (2002). Population pharmacokinetic meta-analysis with efavirenz. International Journal of Clinical Pharmacology and Therapeutics. 40(11). 507–519. 74 indexed citations
19.
Williams, Reed C., et al.. (2001). Chiral analysis of drug substance in clinical plasma extracts using achiral HPLC with circular dichroism detection. Journal of Pharmaceutical and Biomedical Analysis. 25(3-4). 501–509. 11 indexed citations
20.
Joshi, Amita, Parakrama Chandrasoma, & Milton Kiyabu. (1992). Multiple granular cell tumors of the gastrointestinal tract with subsequent development of esophageal squamous carcinoma. Digestive Diseases and Sciences. 37(10). 1612–1618. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caroline Chapman Breakdown of academic impact, for papers by Gabriel J. Robbie Breakdown of academic impact, for papers by James N. Lowder Breakdown of academic impact, for papers by Joseph P. Balthasar Breakdown of academic impact, for papers by Roshini S. Abraham Breakdown of academic impact, for papers by Federico Vázquez Breakdown of academic impact, for papers by Roberto Ceriani Breakdown of academic impact, for papers by Irit Avivi Breakdown of academic impact, for papers by W. James Cook Breakdown of academic impact, for papers by Guglielmo Nasti
Rankless by CCL
2026